Zika virus-specific synthetic molecule can differentiate between prior infections with different flaviviruses

FHS
May 14, 2024
12:47 pm

A newly discovered Zika virus-specific synthetic molecule is capable of differentiating Zika-immune patient samples from samples of patients previously infected with the related dengue virus.

Swap funds or add services? Use of opioid settlement cash sparks strong disagreements

State and local governments are receiving billions of dollars in opioid settlements to address the drug crisis that has ravaged America for decades.

April 15, 2024

How AI is Transforming the Acute Patient Journey

Bob Zdon, Chief Operating Officer for ABOUT Optimizing patient throughput across the acute patient journey is essential if hospitals and health systems are to improve

November 19, 2024

Payers generally meet drug price watchdog’s ‘fair access’ standards, report says

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.